Thromboprophylaxis Part 2

VTE prophylaxis Trauma and Orthopaedics

n) Pregnancy or <6weeks post partum Not part of scoring (see NICE guidance for specific risk factors) system, seek specialist advice on thromboprophylaxis Risk category calculated by electronic VTE assessment pathway 0–2 3 4 or More LOW MODERATE HIGH

  Part, Thromboprophylaxis

Research Bulletin

No part of this publication may be reproduced or transmitted in any form or by any means, ... Extended Thromboprophylaxis Use in Major Pelvic Surgery - A Cross-Sectional Survey of the Current Practice of Pelvic Surgeons ... NIHS VOL 7 Issue 2.qxp_Layout 1 12/03/2015 12:32 Page 6. v Contents CLINICAL RESEARCH

  Part, Thromboprophylaxis

Delayed and Omitted Doses of Medicines Procedure

Where Anticoagulants for thromboprophylaxis are declined, ensure the patient is fully informed of the risk and check that TED stockings are prescribed. Me dication unavailable Attempt to obtain medicine 1. Identify if medication available from ward stock. If not: 2. Identify if patient has brought a suitable supply in with them. If not: 3.

  Procedures, Medicine, Dose, Omitted, Thromboprophylaxis, And omitted doses of medicines procedure

Low Molecular Weight Heparins (LMWHs) Summary …

least 2 consecutive days If INR not in range at point of discharge follow advice on bridging therapy below √ √ √ Red Extended Thromboprophylaxis of VTE for High Risk Patients with History of Thrombosis associated with central venous access On-going whilst central venous access required (For review if clinically events occur

  Thromboprophylaxis

January 2023 Enoxaparin sodium - NottsAPC

Thromboprophylaxis CrCl ≥30mL/min 20mg OD 40mg OD 40mg BD 60mg BD CrCl 15-30mL/min 20mg OD 20mg OD 40mg OD 60mg OD CrCl <15mL/min 20mg OD1 2 20mg OD1 Note: SFH give 40mg OD on RRT and advise to discuss non-RRT with haematology 1This is considered generally safe in this patient group, but consider seeking

  Sodium, Enoxaparin, Thromboprophylaxis, Enoxaparin sodium

Management of Women with Obesity in Pregnancy

BMI 35.0–39.9 (Class 2); and BMI 40 and over (Class 3 or morbid obesity),1,2 which recognise the continuous relationship between BMI and morbidity and mortality. 2 While the majority of the recommendations within this guideline pertain to women with a BMI ≥30, some